| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EURURO.2011.12.055 |
| P698 | PubMed publication ID | 22226583 |
| P50 | author | Harun Fajkovic | Q114316461 |
| Shahrokh Shariat | Q7462263 | ||
| Eugene K. Cha | Q37839556 | ||
| Felix Chun | Q39979798 | ||
| Yair Lotan | Q61862568 | ||
| Michael Rink | Q95321784 | ||
| Pierre I Karakiewicz | Q97332033 | ||
| P2093 | author name string | Amit Gupta | |
| P433 | issue | 4 | |
| P921 | main subject | death certificate | Q708653 |
| P304 | page(s) | 854-855 | |
| P577 | publication date | 2012-01-05 | |
| P1433 | published in | European Urology | Q15763991 |
| P1476 | title | Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma | |
| P478 | volume | 61 |
| Q50062164 | Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder |
| Q37182161 | Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder. |
| Q52673351 | Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. |
| Q48123202 | Adapting the Elixhauser comorbidity index for cancer patients. |
| Q39743020 | Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract |
| Q38812564 | Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract |
| Q90043400 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization |
| Q38876688 | Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer |
| Q50645475 | Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients. |
| Q53994895 | Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. |
| Q40381359 | Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder |
| Q53059593 | Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer. |
| Q36775322 | Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients |
| Q41346526 | Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study |
| Q45843908 | Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma |
| Q90193874 | Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes? |
| Q43582440 | Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? |
| Q41737126 | Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? |
| Q53085995 | Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. |
| Q51292827 | Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. |
| Q40713928 | HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC). |
| Q38154012 | High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. |
| Q89712370 | Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer |
| Q37672870 | Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer |
| Q37672873 | Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. |
| Q41273357 | Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy |
| Q57565102 | Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study |
| Q52942124 | Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different? |
| Q53515170 | Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. |
| Q41127920 | Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy |
| Q52951141 | Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer. |
| Q40932311 | Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma |
| Q41056921 | Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent |
| Q52904959 | Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. |
| Q37584125 | Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study |
| Q33840690 | Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study |
| Q90005331 | Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy |
| Q93128449 | Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer |
| Q51487533 | Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. |
| Q90709729 | Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder |
| Q37584081 | Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy |
| Q47183431 | Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes. |
| Q34422193 | Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience |
| Q36623107 | Risk of cancer-specific mortality following recurrence after radical nephroureterectomy |
| Q41462223 | Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder |
| Q36419132 | Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling |
| Q44893721 | Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years |
| Q90315155 | Role of serum cholinesterase in patients treated with salvage radical prostatectomy |
| Q47356457 | Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification |
| Q41528918 | Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study |
| Q41687794 | The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy |
| Q48007072 | The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. |
| Q53842791 | The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. |
| Q53574858 | The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. |
| Q85962074 | The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study |
| Q90627464 | The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC) |
Search more.